ANI Pharmaceuticals has launched generic Duloxetine Delayed-Release Capsules in 20, 30, and 60 mg doses, providing an alternative to the branded drug Cymbalta. This launch aims to ensure stable supply in a market with limited players, addressing a U.S. market valued at approximately $247 million annually. ANI emphasizes its commitment to patient access and plans to leverage this product within its broader strategy across rare diseases, generics, and branded pharmaceuticals. The company also highlights potential risks such as regulatory approvals and supply chain challenges but remains focused on growth and innovation.
ANI Pharmaceuticals' launch of Duloxetine Delayed-Release Capsules is noted here with Pluang's health sector market data for context. For readers following health stocks, 69 of 150 US health-sector stocks rose and 45 fell on Pluang. Notable movers include ERAS at USD 13.63 (+1.79%), ELAN at USD 23.97 (+1.78%), and ABCL at USD 12.00 (+1.69%), as of Oct 19, 2026 17:11 WIB.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
